Duopharma Biotech Berhad (7148.KL)
MYR 1.16
(0.0%)
MYR 1.16
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 124.51 Million MYR | -4.42% |
| 2022 | 130.62 Million MYR | 6.73% |
| 2021 | 121.91 Million MYR | 8.71% |
| 2020 | 112.43 Million MYR | 6.21% |
| 2019 | 105.96 Million MYR | 14.43% |
| 2018 | 92.12 Million MYR | 13.67% |
| 2017 | 81.16 Million MYR | 36.35% |
| 2016 | 59.52 Million MYR | -18.7% |
| 2015 | 73.1 Million MYR | 32.17% |
| 2014 | 55.2 Million MYR | 14.38% |
| 2013 | 48.26 Million MYR | 13.11% |
| 2012 | 42.67 Million MYR | 4.26% |
| 2011 | 40.92 Million MYR | 1.76% |
| 2010 | 40.22 Million MYR | -6.19% |
| 2009 | 42.87 Million MYR | 8.03% |
| 2008 | 39.68 Million MYR | -12.87% |
| 2007 | 45.55 Million MYR | 24.31% |
| 2006 | 36.64 Million MYR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 37.77 Million MYR | 43.97% |
| 2024 Q2 | 38.67 Million MYR | 4.58% |
| 2023 Q3 | 27.36 Million MYR | -10.08% |
| 2023 Q4 | 24.38 Million MYR | -10.88% |
| 2023 FY | - MYR | -4.42% |
| 2023 Q1 | 40.39 Million MYR | 46.32% |
| 2023 Q2 | 30.43 Million MYR | -24.65% |
| 2022 Q2 | 32.39 Million MYR | -11.47% |
| 2022 Q3 | 33.56 Million MYR | 3.63% |
| 2022 Q4 | 27.6 Million MYR | -17.75% |
| 2022 FY | - MYR | 6.73% |
| 2022 Q1 | 36.58 Million MYR | 42.8% |
| 2021 Q1 | 32.69 Million MYR | 11.85% |
| 2021 Q3 | 32.68 Million MYR | 7.62% |
| 2021 Q4 | 25.62 Million MYR | -21.62% |
| 2021 FY | - MYR | 8.71% |
| 2021 Q2 | 30.37 Million MYR | -7.09% |
| 2020 Q1 | 26.08 Million MYR | 10.82% |
| 2020 FY | - MYR | 6.21% |
| 2020 Q2 | 29.11 Million MYR | 11.58% |
| 2020 Q3 | 27.32 Million MYR | -6.14% |
| 2020 Q4 | 29.22 Million MYR | 6.98% |
| 2019 Q3 | 26.95 Million MYR | -3.82% |
| 2019 FY | - MYR | 14.43% |
| 2019 Q1 | 27.11 Million MYR | -2.34% |
| 2019 Q4 | 23.54 Million MYR | -12.65% |
| 2019 Q2 | 28.02 Million MYR | 3.35% |
| 2018 Q2 | 20.57 Million MYR | 1.9% |
| 2018 FY | - MYR | 13.67% |
| 2018 Q4 | 27.76 Million MYR | 18.59% |
| 2018 Q3 | 23.41 Million MYR | 13.77% |
| 2018 Q1 | 20.19 Million MYR | 5.31% |
| 2017 Q4 | 19.17 Million MYR | -16.59% |
| 2017 FY | - MYR | 36.35% |
| 2017 Q3 | 22.99 Million MYR | 15.81% |
| 2017 Q2 | 19.85 Million MYR | 5.22% |
| 2017 Q1 | 18.86 Million MYR | 41.52% |
| 2016 Q1 | 16.92 Million MYR | -24.82% |
| 2016 Q3 | 14.36 Million MYR | -2.24% |
| 2016 Q2 | 14.69 Million MYR | -13.15% |
| 2016 FY | - MYR | -18.7% |
| 2016 Q4 | 13.33 Million MYR | -7.22% |
| 2015 Q1 | 14.37 Million MYR | -10.37% |
| 2015 FY | - MYR | 32.17% |
| 2015 Q4 | 22.51 Million MYR | -7.15% |
| 2015 Q3 | 24.24 Million MYR | 104.88% |
| 2015 Q2 | 11.83 Million MYR | -17.7% |
| 2014 FY | - MYR | 14.38% |
| 2014 Q4 | 16.04 Million MYR | 19.39% |
| 2014 Q2 | 12.41 Million MYR | -6.77% |
| 2014 Q1 | 13.31 Million MYR | 18.44% |
| 2014 Q3 | 13.43 Million MYR | 8.23% |
| 2013 Q1 | 10.88 Million MYR | -1.21% |
| 2013 Q4 | 11.24 Million MYR | 1.33% |
| 2013 Q3 | 11.09 Million MYR | -26.27% |
| 2013 FY | - MYR | 13.11% |
| 2013 Q2 | 15.04 Million MYR | 38.24% |
| 2012 Q4 | 11.01 Million MYR | 7.96% |
| 2012 Q1 | 10.61 Million MYR | 0.0% |
| 2012 Q2 | 10.85 Million MYR | 2.3% |
| 2012 Q3 | 10.2 Million MYR | -6.0% |
| 2012 FY | - MYR | 4.26% |
| 2011 FY | - MYR | 1.76% |
| 2010 FY | - MYR | -6.19% |
| 2009 FY | - MYR | 8.03% |
| 2008 FY | - MYR | -12.87% |
| 2007 FY | - MYR | 24.31% |
| 2006 FY | - MYR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Kotra Industries Berhad | 70.78 Million MYR | -75.907% |